Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable outcomes in clinical trials for weight management. It works by modulating several pathways : GLP-1 and GIP, that , when activated , help control appetite and improve metabolism . Early findings indicate considerable weight reduction and possible